Premium
A phase II study of risk‐adapted intravenous melphalan in patients with AL amyloidosis
Author(s) -
Mollee Peter,
Tiley Campbell,
Cunningham Ilona,
Moore John,
Prince H. Miles,
Cannell Paul,
Gibbons Steve,
Tate Jill,
Paul Sanjoy,
Mar Fan Helen,
Gill Devinder S.
Publication year - 2012
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2012.09080.x
Subject(s) - melphalan , medicine , al amyloidosis , autologous stem cell transplantation , oncology , cardiac amyloidosis , amyloidosis , transplantation , surgery , immunology , antibody , immunoglobulin light chain
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom